0 CHECKOUT

Russia Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3518017
  • December 2015
  • Region: Russia
  • 91 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Gedeon Richter
  • Krka
  • Pharmstandard
  • Stada AG
  • Veropharm
  • MORE

Russia's healthcare and pharmaceutical markets are in a precarious position due to the country's economic recession. Healthcare in the country remains desperately in need of additional funding, and amendments to Russia's pharmaceutical legislation will hinder market access for drugmakers due to complex medicine registration laws and increased governmental influence on pricing. With significant challenges facing both sectors, we see a reduction in attractiveness of the operating environment to multinational pharmaceutical firms.

Headline Expenditure Projections
- Pharmaceuticals: RUB885.67bn (USD22.96bn) in 2014 to RUB1.02trn (USD16.66bn) in 2015; +14.8%
in local currency terms and -27.4% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: RUB4.85trn (USD125.61bn) in 2014 to RUB5.29trn (USD86.74bn) in 2015; +9.2% in local currency terms and -30.9% in US dollar terms. Forecast unchanged from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Gedeon Richter
  • Krka
  • Pharmstandard
  • Stada AG
  • Veropharm
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Russia 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2013-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2013-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2013-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2013-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2013-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2013-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2013-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Russia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2013-2019)

Industry Risk/Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Russia Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Environment

Pricing Regime

Reference Pricing

Medicines Financing

Reimbursement Regime

Protectionist Measures

Market Overview

Epidemiology
Table: Russia: Causes Of Mortality (mortality rate per 100,000 population)
Table: Cancer Incidence Rates, 2012-2035

Healthcare Sector
Table: Healthcare Resources (Russia 2009-2014)
Table: Healthcare Personnel (Russia 2009-2014)
Table: Healthcare Activity (Russia 2009-2014)

Research & Development

Clinical Trials

Competitive Landscape

Pharmaceutical Sector

Research-Based Industry

Recent Developments
Table: Multinational Market Activity

Generic Drugmakers

Pharmaceutical Retail Sector

Company Profile

Gedeon Richter

Krka

Pharmstandard

Stada AG

Veropharm

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Russia 1990-2025)
Table: Key Population Ratios (Russia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Russia 1990-2025)
Table: Population By Age Group (Russia 1990-2025)
Table: Population By Age Group % (Russia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Gedeon Richter
Krka
Pharmstandard
Stada AG
Veropharm

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S